Methylene blue improves the hepatopulmonary syndrome.
Groneberg
D A
DA
Fischer
A
A
D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006207:Half-Life; D020065:Hepatopulmonary Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008751:Methylene Blue / Q000008:administration & dosage* / Q000493:pharmacokinetics; D010100:Oxygen / Q000097:blood
D004791:Enzyme Inhibitors; D010100:Oxygen; D008751:Methylene Blue